Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-06

Clinical Trial Update: FS-67 in the Treatment of Pediatric Patients With Ankle Sprain [Phase 4]

View source ↗

Summary

Phase 4 trial update for FS-67 in pediatric ankle sprain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FS-67

Snippet

Sponsor: Hisamitsu Pharmaceutical Co., Inc. | Conditions: Ankle Sprain | Phase 4 | Status: COMPLETED | Results posted: 2022-10-06